GU Cancers 2019 | Prostate cancer radiotherapy planning with Gallium-labelled PSMA-11 PET/CT imaging

Name: Prostate cancer radiotherapy planning with Gallium-labelled PSMA-11 PET/CT imaging
Uploaded: 2019-03-06T15:33:04Z
Duration: 3 min 28 s
Description: Jeremie Calais, MD, of the University of California, Los Angeles, CA, speaks at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA and discusses a Phase III randomised trial study (NCT03582774) investigating the efficacy of radiotherapy planning using Gallium-labelled PSMA-11 PET/CT imaging.

Jeremie Calais • 6 Mar 2019

GU Cancers 2019

Genitourinary Cancer Prostate Cancer

Jeremie Calais, MD, of the University of California, Los Angeles, CA, speaks at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA and discusses a Phase III randomised trial study (NCT03582774) investigating the efficacy of radiotherapy planning using Gallium-labelled PSMA-11 PET/CT imaging.